
RealBio Technology Transforms Research & Pharmaceutical Testing
RealBio’s technology allows cells grown in a laboratory setting to develop as they would in a normal human body.
RealBio’s technology allows cells grown in a laboratory setting to develop as they would in a normal human body.
Sonitus Medical, Inc., a medical device company that manufactures the world’s first non-surgical and removable hearing prosthetic to transmit sound via the teeth, recently announced that it has received CE Mark certification.
S.E.A. Medical Systems, Inc., a privately held medical device company dedicated to making intravenous drug delivery safer for patients, recently welcomed two additions to their Board of Directors.
U.S. researchers say a new technology can safely place sensitive electronics inside the human heart for better diagnosis of heart rhythm irregularities.
A new market research report on the In Vitro Diagnostic market is now available in the reportlinker.com catalogue.
OneMedPlace is gearing up for OneMedForum NY 2011, the company’s 2nd annual Trans-Atlantic Conference to be held June 23-24 , 2011 in New York City.
Last year, Accord Biosciences was awarded a Phase II National Institutes of Health Small Business Innovation Research grant of $1.3M to develop a point-of-care diagnostic for pulmonary arterial hypertension.
Compumedics Grael High-Definition PSG/EEG system and their ProFusion nexus Lab Management system, is now the world’s first accredited and paperless sleep lab’s database monitoring technology of choice.
Interface Biologics Inc. (IBI), a privately held commercial stage developer of transformative biomedical-polymer products recently announced the appointment of Arthur L. Rosenthal to Chairman of its Board of Directors.
Time is critical when a patient suffers from a stroke.
Copyright © 2025 | WordPress Theme by MH Themes